Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Refractory Chronic Gout”

9 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 9 of 9 results

Testing effectiveness (Phase 2)Study completedNCT03905512
What this trial is testing

Compare the Efficacy of SEL-212 to KRYSTEXXA® in Gout Participants Refractory to Conventional Therapy

Who this might be right for
Chronic Gout
Selecta Biosciences, Inc. 170
Large-scale testing (Phase 3)Study completedNCT04513366
What this trial is testing

SEL-212 in Patients With Gout Refractory to Conventional Therapy

Who this might be right for
Chronic Gout
Swedish Orphan Biovitrum 112
Not applicableStudy completedNCT01466166
What this trial is testing

Observational Study of the Use of Pegloticase (KRYSTEXXA®) in Refractory Chronic Gout

Who this might be right for
Refractory Chronic Gout
Horizon Pharma Rheumatology LLC 188
Large-scale testing (Phase 3)Study completedNCT00675103
What this trial is testing

Re-exposure Study of Pegloticase Intravenous (i.v.) in Symptomatic Gout Patients

Who this might be right for
Chronic Gout Refractory to Conventional Therapy
Savient Pharmaceuticals 7
Testing effectiveness (Phase 2)Looking for participantsNCT07116746
What this trial is testing

Evaluation of Efficacy and Safety of AR882 and XOI Co-administration in Uricase Treatment Failed Patients

Who this might be right for
GoutGouty ArthritisHyperuricemia+4 more
Arthrosi Therapeutics 25
Testing effectiveness (Phase 2)Study completedNCT02598596
What this trial is testing

Tolerization Reduces Intolerance to Pegloticase and Prolongs the Urate Lowering Effect

Who this might be right for
Gout
Ampel BioSolutions, LLC 132
Large-scale testing (Phase 3)Study completedNCT04596540
What this trial is testing

SEL-212 in Patients With Gout Refractory to Conventional Therapy II

Who this might be right for
Chronic Gout
Swedish Orphan Biovitrum 153
Post-approval studies (Phase 4)Active Not RecruitingNCT06229145
What this trial is testing

A Trial to Investigate the Non-inferiority of Pegloticase Administered Every 4 Weeks (Q4W) With MTX Compared With Every 2 Weeks (Q2W) With MTX in Participants With Uncontrolled Refractory Gout

Who this might be right for
Gout
Amgen 262
Post-approval studies (Phase 4)Study completedNCT04762498
What this trial is testing

A Phase 4, Open-label Study of KRYSTEXXA® (Pegloticase) Co-administered With Methotrexate (MTX) in Patients With Uncontrolled Gout (FORWARD OL)

Who this might be right for
Uncontrolled GoutChronic Gout
Amgen 50